ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 273

Incidence of Systemic Lupus Erythematosus By Income: A Nationwide Study

Ali Duarte-Garcia1, Cynthia S. Crowson2, Rozalina McCoy1, Stephanie Schilz3, Holly Van Houten4, Lindsey Sangaralingham4, Vaidehi R. Chowdhary5, Shreyasee Amin6, Kenneth J. Warrington7, Eric L. Matteson8 and Nilay Shah9, 1Mayo Clinic College of Medicine and Science, Rochester, MN, 2Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, 3Health Sciences Research, Mayo Clinic, Rochester, MN, 4Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, 5Internal Medicine, Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, 6Rheumatology, Mayo Clinic, Rochester, MN, 7Rheumatology, Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN, 8Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, 9Health Care Policy and Research, Mayo Clinic College of Medicine and Science, Rochester, MN

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: race/ethnicity, socioeconomic factors and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Healthcare Disparities in Rheumatology Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: The incidence of systemic lupus erythematosus (SLE) varies significantly across patients from different racial/ethnic backgrounds, and is highest in non-Caucasian populations.  In addition, poverty has been associated with increased SLE severity and mortality, independent of race/ethnicity. How the incidence of SLE varies by income level, the main determinant of poverty, is unknown. 

Methods: Using OptumLabs Data Warehouse, a large administrative database of commercially insured and Medicare Advantage beneficiaries, we identified adults with newly diagnosed SLE (ascertained using three ICD-9/10 codes at least 30 days apart) from 2013-2017. Patients had at least two years of enrollment prior to SLE diagnosis. Patients of ≥65 years were excluded due to difficulty in estimating income after retirement. Income was based predominately on self-report or when data were missing, derived rule sets were used. Income was missing in 5% of the sample. We estimated the incidence rate (IR) of SLE per 100,000 person-years stratified by income and racial/ethnic categories with age- and sex-adjusted adjustment to the 2010 US total population aged 18-64 years.

Results: We identified 2810 patients with newly diagnosed SLE. The average age (SD) was 44.9 (12.5), 62% of the patients were Caucasian, 16% Black, 15% Hispanic, 7% Asian/other, and 88% were female.  The overall age-, sex- and race/ethnicity-adjusted IR was 3.4 (95% confidence interval: 3.3-3.5) per 100,000. SLE incidence was 8 times higher among women (9.1) than men (1.2). The incidence rate among Blacks was twice as high as that of Caucasians, and was moderately higher in Hispanic and Asian/other compared to Caucasians. SLE incidence was 12% higher in those with <$40,000 household income than those with ≥$40,000 income. Caucasians with <$40,000 income had 20% higher SLE incidence than those with ≥$40,000 income, but there was no evidence of a differential income effect among minorities  

Conclusion: The incidence of SLE is highest among Blacks, and Hispanics.  Lower income is associated with higher incidence of SLE in Caucasians; this differential effect of income on disease incidence was not seen in minorities.

Table. Incidence Rates of SLE per 100,000 person years according to income

Income

Overall

Caucasian

Black

Hispanic

Asian/Other

<$40,000

4.4

3.9

        6.0

5.7

3.9

$40000 – $99,000

3.8

3.3

6.0

5.7

3.4

$100,000+

3.8

3.2

5.9

5.4

3.8

Unknown

1.7

1.5

3.3

2.4

1.3

OVERALL

3.4

2.9

5.1

2.4

3.1


Disclosure: A. Duarte-Garcia, None; C. S. Crowson, None; R. McCoy, None; S. Schilz, None; H. Van Houten, None; L. Sangaralingham, None; V. R. Chowdhary, None; S. Amin, None; K. J. Warrington, GlaxoSmithKline, 2,Eli Lilly and Co., 2,Sanofi, 5; E. L. Matteson, None; N. Shah, None.

To cite this abstract in AMA style:

Duarte-Garcia A, Crowson CS, McCoy R, Schilz S, Van Houten H, Sangaralingham L, Chowdhary VR, Amin S, Warrington KJ, Matteson EL, Shah N. Incidence of Systemic Lupus Erythematosus By Income: A Nationwide Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/incidence-of-systemic-lupus-erythematosus-by-income-a-nationwide-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-of-systemic-lupus-erythematosus-by-income-a-nationwide-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology